BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8007993)

  • 1. E2F and its developmental regulation in Xenopus laevis.
    Philpott A; Friend SH
    Mol Cell Biol; 1994 Jul; 14(7):5000-9. PubMed ID: 8007993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of Xenopus laevis DP proteins.
    Girling R; Bandara LR; Ormondroyd E; Lam EW; Kotecha S; Mohun T; La Thangue NB
    Mol Biol Cell; 1994 Oct; 5(10):1081-92. PubMed ID: 7865876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA
    Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative E2F inhibits progression of the cell cycle after the midblastula transition in Xenopus.
    Tanaka T; Ono T; Kitamura N; Kato JY
    Cell Struct Funct; 2003 Dec; 28(6):515-22. PubMed ID: 15004421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Fattaey AR; Harlow E; Helin K
    Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Cao L; Faha B; Dembski M; Tsai LH; Harlow E; Dyson N
    Nature; 1992 Jan; 355(6356):176-9. PubMed ID: 1530885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
    Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein.
    Dimri GP; Nakanishi M; Desprez PY; Smith JR; Campisi J
    Mol Cell Biol; 1996 Jun; 16(6):2987-97. PubMed ID: 8649410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
    Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
    Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.
    Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A
    Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
    Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
    Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.
    Devoto SH; Mudryj M; Pines J; Hunter T; Nevins JR
    Cell; 1992 Jan; 68(1):167-76. PubMed ID: 1310073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cdk2 kinase with the transcription factor E2F during S phase.
    Pagano M; Draetta G; Jansen-Dürr P
    Science; 1992 Feb; 255(5048):1144-7. PubMed ID: 1312258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.